Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Encapsule Medical

Request full access

Privately-held medical device company focused on minimally invasive breast biopsy and tissue removal technologies

San Francisco, United StatesFounded 1998Biotech & Life Sciences

About Encapsule Medical

Encapsule, Inc. operates as a precision medicine company focused on transforming oncology by personalizing cancer therapy. Founded in 2018 by University of Connecticut graduates Armin Rad, Ph.D., Leila Daneshmandi, Ph.D., and Reza Amin, Ph.D., the company was formed based on the founders' technical experience in biomedical and mechanical engineering to improve cancer treatment procedures. Rad and Daneshmandi, with backgrounds in biomedical engineering, and Amin, in mechanical engineering, met during their graduate studies and established the company to leverage their collective expertise.

The core of Encapsule's business is its proprietary "tumor-on-a-chip" system. This technology enables the growth of patient-derived cancer cells in microtumors outside the body. These microtumors are then screened against various chemotherapeutic drugs, allowing oncologists to select the most effective treatment regimen for a specific patient before administration. This process aims to reduce unnecessary and painful treatment cycles, lower overall healthcare costs, and improve patient outcomes. The service provides a report on the patient's therapeutic response profile in under seven days.

The company targets several key client segments. For oncologists and their patients, the platform provides data to personalize treatment, potentially increasing success rates and quality of life. For pharmaceutical companies, Encapsulate offers its platform and a substantial biobank of patient-derived samples for pre-clinical trials, patient stratification, and mechanism studies. This allows for more efficient drug development and the identification of new therapeutic targets.

Encapsule has achieved significant milestones, securing notable grant funding. It was awarded a $1.25 million SBIR Phase II grant from the National Science Foundation to advance its chemotherapy selection platform for pancreatic and colorectal cancers. More recently, in July 2025, the company received a $3.63 million Phase 1 grant from NASA to develop a "Metastasis-on-a-Chip" technology. This project, in partnership with NASA and Space Tango, will leverage microgravity environments on the International Space Station to better understand cancer metastasis.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
22.3/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Non-Invasive medical devices and treatments, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Aug 2006 $30M $120M Undisclosed —
SERIES B✓Equity / VC Oct 2004 $2.9M $12M Undisclosed —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Encapsule Medical website traffic

Latest recorded traffic for Encapsule Medical is 140 monthly website visits.

Latest monthly visits140
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Encapsule Medical in the San Francisco ecosystem

Live from Dealroom

The Encapsule Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Encapsule Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Encapsule Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.